Effects of epoetin alfa on anemia and patient-reported outcomes in patients with non-small cell lung cancer receiving chemotherapy: Results of a European, multicenter, randomized, controlled study

European journal of Clinical and Medical Oncology

Volumn 3, Issue 2, 2011, Pages 49-56

  Milroy, Robert ^a   Bajetta, Emilio ^b   van den Berg, Paul M ^c   O'Brien, Mary E R ^d   Perez Manga, Gumersindo ^e   Georgoulias, Vassilis ^f   Greil, Richard ^g   Ramlau, Rodryg ^h  

^a STOBHILL HOSPITAL   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c ALBERT SCHWEITZER HOSPITAL   (Netherlands)

^d ROYAL MARSDEN HOSPITAL   (United Kingdom)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^f UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^g PARACELSUS MEDICAL UNIVERSITY   (Austria)

^h Oncology Department   (Poland)

Author keywords

Anemia; Chemotherapy; Epoetin alfa; Non_small cell lung carcinoma; Quality of life

Indexed keywords

HEMOGLOBIN; PLATINUM DERIVATIVE; RECOMBINANT ERYTHROPOIETIN;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; ALOPECIA; ANEMIA; ANOREXIA; ASTHENIA; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER FATIGUE; CANCER LINEAR ANALOGUE SCALE; CANCER RADIOTHERAPY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CONSTIPATION; CONTROLLED STUDY; COUGHING; DEPRESSION; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FEVER; FUNCTIONAL ASSESSMENT OF CANCER THERAPY ANEMIA; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; HYPOTENSION; INFECTION; LEUKOPENIA; LUNG CANCER SYMPTOM SCALE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NAUSEA; OPEN STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAIN; PHASE 3 CLINICAL TRIAL; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REVIEW; SEPSIS; SOMNOLENCE; STOMATITIS; THORAX PAIN; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; UROGENITAL TRACT DISEASE; VOMITING;

EID: 79958170350     PISSN: 17598958     EISSN: 17598966     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Ludwig H, VanBelle S, Barrett-Lee P, et al. The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer. 2004;40:2293-2306.
2. Cella D. The effects of anemia and anemia treatment on the quality of life of people with cancer. Oncology. 2002;16:125-132.
3. Dodd RY. The risk of transfusion-transmitted infection. N Engl J Med. 1992;327:419-421.
4. Glaspy J, Bukowski R, Steinberg D, Taylor C, Tchekmedyian S, Vadhan- Raj S. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol. 1997;15:1218-1234.
5. Demetri GD, Kris M, Wade J, Degos L, Cella D. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit study group. J Clin Oncol. 1998;16:3412-3425.
6. Gabrilove JL, Cleeland CS, Livingston RB, Sarokhan B, Winer E, Einhorn LH. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol. 2001;19: 2875-2882.
7. Abels R. Erythropoietin for anaemia in cancer patients. Eur J Cancer. 1993;29A(Suppl. 2):S2-S8.
8. Littlewood TJ, Bajetta E, Nortier JW, Vercammen E, Rapoport B. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2001;19:2865-2874.
9. Witzig TE, Silberstein PT, Loprinzi CL, et al. Phase III, randomized, double-blind study of epoetin alfa versus placebo in anemic patients with cancer undergoing chemotherapy. J Clin Oncol. 2005;23:2606-2617.
10. Crawford J, Cella D, Cleeland CS, et al. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer. 2002;95:888-895.
11. Del Mastro L, Gennari A, Donati S. Chemotherapy of non-small-cell lung cancer: Role of erythropoietin in the management of anemia. Ann Oncol. 1999;10(Suppl. 5):S91-S94.
12. World Medical Association. Declaration of Helsinki: Recommendations guiding medical doctors in biomedical research involving human subjects, 1989 version. Available from: http://www1.va.gov/oro/apps/compendium/Files/helsinki89.htm. Accessed January 5, 2010.
13. Henke M, Laszig R, Rube C, et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: Randomised, double-blind, placebo-controlled trial. Lancet. 2003;362:1255-1260.
14. Leyland-Jones B, Semiglazov V, Pawlicki M, et al. Maintaining normal hemoglobin concentrations with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study. J Clin Oncol. 2005;23:5960-5972.
15. Overgaard J, Hoff C, Sand Hansen H, et al. Randomized study of the importance of Novel Erythropoiesis Stimulating Protein (Aranesp®) for the effect of radiotherapy in patient with primary squamous cell carcinoma of the head and neck (HNSCC)-The Danish Head and Neck Cancer Group DAHANCA 10 randomized trial. Eur J Cancer. 2007;5(Suppl.):7.
16. Grote T, Yeilding AL, Castillo R, et al. Efficacy and safety analysis of epoetin alfa in patients with small-cell lung cancer: A randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2005;23:9377-9386.
17. Blohmer JU, Wurschmidt F, Petry U, Weise G, Sehouli J, Kimmig R. Sixth interim analysis of a prospective, randomized, open and controlled AGOand NOGGO-intergroup study: Sequential adjuvant chemoradiotherapy with vs without epoetin alfa for pts with high-risk cervical cancer [abstract]. Proc Am Soc Clin Oncol. 2003;22:1798.
18. Moebus V, Lueck H, Thomssen C, et al. The impact of epoetin-alpha on anemia, red blood cell (RBC) transfusions, and survival in breast cancer patients (pts) treated with dose-dense sequential chemotherapy: Mature results of an AGO phase III study (ETC trial). J Clin Oncol. 2007;25(18S):569.
19. Pirker R, Ramlau RA, Schuette W, Zatloukal P, Ferreira I, Lillie T, Vansteenkiste JF. Safety and efficacy of darbepoetin alpha in previously untreated extensive-stage small-cell lung cancer treated with platinum plus etoposide. J Clin Oncol. 2008;26:2342-2349.